As Medical Director of Infection Prevention and Hospital Epidemiology at Hoag,
Philip Robinson, MD, FIDSA, has led the COVID-19 efforts for Hoag. In January, the Orange County Health
Care Agency selected Hoag to care for
California’s first COVID-19 patient, who has since fully recovered. In March, he provided advice on COVID-19
to the community during the
City of Irvine’s COVID-19 Virtual Town Hall in March.
Dr. Robinson is the principal investigator at Hoag for the
Gilead COVID-19 Remdesivir Clinical Trial and sub-investigator for Expanded Access to Convalescent Plasma for the
treatment of patients with COVID-19.
Dr. Robinson has played a crucial role in keeping Hoag staff and physicians
informed on COVID-19-related advancements, whether in research or clinical
care, and continues to be a positive guiding force. The staff often describes
him as an angel on earth, noting that his calm and welcoming demeanor
has helped get them through some of the toughest days during this crisis.
Serving Hoag since 2008, Dr. Robinson’s other areas of expertise
include antimicrobial stewardship at Hoag Memorial Hospital Presbyterian and
Hoag Orthopedic Institute and long-term care facilities. He is co-chair of the Providence St. Joseph
Health Infectious Disease Clinical Decision Team and a Fellow of the Infectious
Disease Society of America.
Dr. Robinson has served by invitation on several state and national committees.
He is currently the immediate past-president of the Infectious Disease
Association of California and the past-chair of the Healthcare Associated
Infection Workgroup of the Hospital Quality Institute of the California
Hospital Association. In addition to the Orange County Health Care Agency,
he works closely with the California Department of Public Health and the
Centers for Disease Control and Prevention.
Dr. Robinson earned his medical degree at Michigan State University, College
of Human Medicine. He completed his Infectious Disease Fellowship at USC,
Los Angeles County Medical Center, and an Internal Medicine Internship
and Residency at Harbor-UCLA Medical Center.
To view the original article, please visit the
Greater Irvine Chamber.